CompoAtlas

Fer

Food supplement declared in France, declaration No 2023-7-1034, decision dated 20 July 2023

Fer is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
SOULDI FADILA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélule
Directions for use
1 gélule par jour avec un grand verre d'eau
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes

Declaration 330293, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Bisglycinate ferreuxFer40 mg (niveau de sécurité)14 mg

Additives

E460, E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2023. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Il est recommandé aux femmes enceintes et allaitantes de consulter un professionnel de santé avant toute complémentation.Déconseillé aux personnes souffrant de maladies ayant pour conséquence une accumulation anormale de fer (hémochromatose, polyglobulie…). Réservé à l'adulte.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line